Tamoxifen As an Effective Neuroprotectant Against Early Brain Injury and Learning Deficits Induced by Subarachnoid Hemorrhage: Possible Involvement of Inflammatory Signaling

Xuebo Sun,Chengyuan Ji,Tong Hu,Zhong Wang,Gang Chen

DOI: https://doi.org/10.1186/1742-2094-10-157

IF: 9.3

2013-01-01

Journal of Neuroinflammation

Abstract:Tamoxifen, a selective estrogen receptor modulator, has successfully been used to treat several animal models of brain injury, but the underlying mechanisms remain unclear. This study was undertaken to evaluate the effect of tamoxifen on the toll-like receptor 4 (TLR4)- and nuclear factor-κB (NF-κB)-related inflammatory signaling pathway and secondary brain injury in rats after subarachnoid hemorrhage (SAH).